BRIEF published on 11/05/2025 at 18:01, 11 months 9 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 11 months 9 days ago Christian Mias nommé nouveau PDG de SCHOTT Pharma SCHOTT Pharma Nomination Du PDG Changement De Leadership Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 11 months 9 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 1 year 2 months ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
BRIEF published on 08/12/2025 at 07:05, 1 year 2 months ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 1 year 2 months ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 10:00, 1 year 2 months ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 09:58, 1 year 2 months ago SCHOTT Pharma met à jour ses prévisions de chiffre d'affaires et d'EBITDA pour l'exercice 2025 Résultats Financiers SCHOTT Pharma Marge EBITDA Croissance Des Revenus Orientations Pour L'exercice 2025
BRIEF published on 08/05/2025 at 09:58, 1 year 2 months ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
Published on 10/15/2026 at 11:00, 1 hour 20 minutes ago Blue Lagoon Records Its First Finalized Gold And Silver Production From Dome Mountain
Published on 10/15/2026 at 08:07, 4 hours 13 minutes ago Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 10/15/2026 at 08:02, 4 hours 18 minutes ago Southern Energy Corp. Announces Successful Cotton Valley Completion Results at Williamsburg
Published on 10/14/2026 at 23:55, 12 hours 25 minutes ago First Helium Announces Strategic Shallow Heavy Oil Acquisition
Published on 10/15/2026 at 12:10, 9 minutes ago MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain
Published on 10/15/2026 at 12:05, 14 minutes ago DOJO Expands BLAST X: A Fresh New Chapter Inspired by Nature, Introducing Five Autumn Flavours in Germany
Published on 10/15/2026 at 12:05, 14 minutes ago Blackview XPLORE 6 Now Available: 15km Ultra-Long-Range Photography, Dimensity 9400+, and 12000mAh Battery
Published on 10/15/2026 at 12:00, 20 minutes ago Symrise expands global production platform for sustainable musk fragrance ingredient
Published on 10/15/2026 at 11:30, 50 minutes ago pferdewetten.de AG: Supervisory Board appoints Frank Hartmann as CFO and Co-CEO
Published on 10/15/2026 at 07:27, 4 hours 52 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
Published on 10/15/2026 at 07:27, 4 hours 52 minutes ago Saint-Gobain renforce son offre pour le marché des infrastructures en Amérique du Nord avec l’acquisition de D.S. Brown dans la chimie de la construction
Published on 10/14/2026 at 18:00, 18 hours 20 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 18 hours 20 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
